Your session is about to expire
← Back to Search
NAC + Albuterol for Asthma (ENACT Trial)
ENACT Trial Summary
This trialevaluates 20% NAC to treat severe asthma affecting the airways, using CT imaging and a crossover design.
ENACT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowENACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ENACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have smoked tobacco or other substances in the past year or have a history of smoking more than 10 pack-years.I am between 18 and 80 years old.My lung function remains strong after treatment.I have a chronic lung condition that affects my breathing.I have been using inhaled steroids for my asthma for 3 months or more.I have a history of asthma.
- Group 1: 0.9% saline
- Group 2: 20% n-acetylcystine (NAC)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the combination of n-acetylcystine and albuterol been declared safe by government regulators?
"Our team at Power has rated n-acetylcystine + albuterol as a 3 on our safety scale, implying it is an approved treatment due to the completion of Phase 4 trials."
Who is eligible to join this research study?
"This clinical trial is seeking 30 individuals with asthma, aged between 18 and 80. Qualified applicants can expect to be accepted in the study."
What is the enrollment capacity of this medical study?
"Affirmative. According to clinicaltrials.gov, this research is still recruiting participants and was initially posted on February 20th 2019. Recent alterations were made on January 29th 2022, with the aim of enrolling 30 people at a single trial site."
What ailments can be ameliorated with a combination of n-acetylcystine and albuterol?
"Patients who suffer from vasomotor rhinitis, bronchodilator agents and chronic obstructive pulmonary disease can benefit from n-acetylcystine + albuterol therapy."
Is this trial actively searching for participants at the moment?
"Clinicaltrials.gov indicates that this experiment is actively recruiting participants; it was initially posted on February 20th 2019 and recently updated January 29th 2022."
Are those over the age of 35 eligible to participate in this study?
"To take part in this trial, patients must be aged between 18 and 80. Furthermore, there are additional studies for those under 18 (130) and over 65 (233)."
How have n-acetylcystine and albuterol been combined in past research efforts?
"Presently, 51 trials for the combination of n-acetylcystine and albuterol are ongiong. Of those studies, 7 have reached Phase 3 in development. Furthermore, there is a total of 90 locations across America running these tests; most notably located in Ann Arbor, Michigan."
Share this study with friends
Copy Link
Messenger